EUIPO conference: Avoid TM cannabis slang ‘like the plague’

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EUIPO conference: Avoid TM cannabis slang ‘like the plague’

Gordon-Humphreys-RHS-EUIPO-IPCLC2022Alicante
The EUIPO's Gordon Humphreys (R) in discussion with fellow panellist Francesco Mattina (L)

The chair of the EUIPO’s First and Third Boards of Appeal gave an entertaining rundown of how examiners weed out cannabis trademarks

Cannabis trademark filers should choose their words carefully and “avoid like the plague” any slang words associated with the plant, said the chairperson of the EUIPO’s First and Third Boards of Appeal at a conference in Alicante today, July 7.

Gordon Humphreys, speaking on a panel moderated by Managing IP’s senior reporter Max Walters at the IP Case Law Conference, gave an overview of cannabis trademark filings and how the EUIPO boards approach them.

As he delved into the background, he mistakenly said the European Commission had been cultivating hemp – rather than discussing the issues around it – prompting plenty of laughter among the audience and a slightly sheepish self-correction from Humphreys himself.

He soon noted that EU cannabis filings have boomed in the past few years, though three quarters of them never make it onto the register.

That’s partly because there is no specific EU-wide legislation dealing with cannabis marks, he explained, but also because of the challenges such marks face when it comes to public policy, lack of distinctiveness, and descriptiveness.

Public policy is the biggest sticking point, particularly as EU member states’ norms vary greatly, Humphreys added.

The boards therefore often focus on the perception of consumers “with reasonable sensitivities and thresholds”, and those who encounter cannabis signs in their day-to-day lives.

“So it’s not acceptable to have a sign that trivialises the war on drugs,” he gave as one example.

However, cannabis filers often don’t help themselves in their choice of names, Humphreys added, noting that “imagination is often sorely lacking”.

Reflecting on two rejections, he said the boards vetoed a figurative application for simply ‘Cannabis’ (beers and alcoholic beverages), and another for ‘Cannubis’ (e-publication on medicinal cannabis), both for being descriptive.

Humphreys ended by saying cannabis applicants should avoid drug-related imagery or symbols, as well as colloquial terms like ‘pot’, and should minimise or omit references to ‘cannabis’ or ‘hemp’.

He reminded the audience that trademark registration doesn’t guarantee usability, owing to a separate regulatory system for cannabis products.

The two-day conference ends tomorrow, July 8. You can read more coverage here.

more from across site and ros bottom lb

More from across our site

A UK government consultation on AI and copyright, a patent blow for Lenovo and a trademark row over cider were among the big talking points this week
Our most popular stories of the year included a rundown of the 50 most influential people in IP, our in-house ones to watch, and UPC news
Awards
It is time to submit nominations for the sixth annual Life Sciences Awards EMEA
Keejeong Kim, who returned to Yulchon after a four-year gap, said he was intrigued by the opportunity to work on neighbouring areas of law to IP
The IP consulting firm hopes to expand its services and outreach with the support of investors VSS Capital Partners and Century Equity Partners
This update includes a ruling from the Court of Appeal, a judgment of the Paris Local Division, news of upcoming hearings, and predictions for 2025
US counsel review the key copyright and trademark trends of 2024, including generative AI disputes and SCOTUS cases
If 2024 is anything to go by, the next 12 months could see more IP firms seek investment opportunities while IP lawyers are increasingly likely to work alongside other functions
Practitioners reflect on the impact of USPTO guidance, as well as PTAB and litigation trends
We discuss Managing IP’s 50 most influential people in IP list and look back on the biggest talking points in the last month
Gift this article